With agencies dueling to regulate nursing homes, aligning priorities for a strategic compliance program may be more challenging than ever.

Natera, Inc., a global leader in cell-free DNA and precision medicine, today announced the publication of a new prospective clinical trial in Transplantation Direct . The study, which was conducted by ...